Intrinsic Value of S&P & Nasdaq Contact Us

Arcus Biosciences, Inc. RCUS NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$28.00
+21.7%

Arcus Biosciences, Inc. (RCUS) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AGIO, ANNX, APLS, AVRO, BEAM and others.

RCUS has a market capitalization of $2.32B, compared to an average peer market cap of $2.64B.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message